These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25989949)

  • 1. Cross-talk between systemic and cerebral inflammation in depressive disorders: Relevance to pathogenesis and treatment.
    Viscogliosi G
    Psychiatry Clin Neurosci; 2015 Aug; 69(8):506-7. PubMed ID: 25989949
    [No Abstract]   [Full Text] [Related]  

  • 2. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
    Martin C; Tansey KE; Schalkwyk LC; Powell TR
    Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers subtyping major depressive disorder.
    Kunugi H; Hori H; Ogawa S
    Psychiatry Clin Neurosci; 2015 Oct; 69(10):597-608. PubMed ID: 25825158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder.
    Maurya PK; Noto C; Rizzo LB; Rios AC; Nunes SO; Barbosa DS; Sethi S; Zeni M; Mansur RB; Maes M; Brietzke E
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():134-44. PubMed ID: 26348786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in major depressive disorder: the role of mass spectrometry.
    Woods AG; Iosifescu DV; Darie CC
    Adv Exp Med Biol; 2014; 806():545-60. PubMed ID: 24952202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.
    Jentsch MC; Van Buel EM; Bosker FJ; Gladkevich AV; Klein HC; Oude Voshaar RC; Ruhé EG; Eisel UL; Schoevers RA
    Biomark Med; 2015; 9(3):277-97. PubMed ID: 25731213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs: A narrative review.
    Manoliu A; Bosch OG; Brakowski J; Brühl AB; Seifritz E
    J Affect Disord; 2018 Jan; 225():630-646. PubMed ID: 28889049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder.
    Saito T; Tamura M; Chiba Y; Katsuse O; Suda A; Kamada A; Ikura T; Abe K; Ogawa M; Minegishi K; Yoshimi R; Kirino Y; Ihata A; Hirayasu Y
    J Neurol Sci; 2017 Aug; 379():127-130. PubMed ID: 28716225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders.
    Sethi S; Hayashi MA; Sussulini A; Tasic L; Brietzke E
    World J Biol Psychiatry; 2017 Oct; 18(7):506-520. PubMed ID: 26555297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What have we learned about the neurobiology of major depression?
    Oquendo MA; Parsey RV
    Am J Psychiatry; 2007 Apr; 164(4):540-2. PubMed ID: 17403962
    [No Abstract]   [Full Text] [Related]  

  • 11. In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.
    Lener MS; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1344():50-65. PubMed ID: 25854817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders.
    Tan HZ; Li H; Liu CF; Guan JT; Guo XB; Wen CH; Ou SM; Zhang YN; Zhang J; Xu CT; Shen ZW; Wu RH; Wang XQ
    Sci Rep; 2016 Nov; 6():37343. PubMed ID: 27869127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy.
    Lin E; Tsai SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():334-40. PubMed ID: 25708651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphenol A alters transcript levels of biomarker genes for Major Depressive Disorder in vascular endothelial cells and colon cancer cells.
    Ribeiro-Varandas E; Pereira HS; Viegas W; Delgado M
    Chemosphere; 2016 Jun; 153():75-7. PubMed ID: 27010169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of glutamate and cortical thickness is restricted to regions subserving trait but not state markers in major depressive disorder.
    Li M; Metzger CD; Li W; Safron A; van Tol MJ; Lord A; Krause AL; Borchardt V; Dou W; Genz A; Heinze HJ; He H; Walter M
    J Affect Disord; 2014 Dec; 169():91-100. PubMed ID: 25173431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder.
    Kahl KG; Rudolf S; Stoeckelhuber BM; Dibbelt L; Gehl HB; Markhof K; Hohagen F; Schweiger U
    Am J Psychiatry; 2005 Jan; 162(1):168-74. PubMed ID: 15625216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.
    Doolin K; Farrell C; Tozzi L; Harkin A; Frodl T; O'Keane V
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal Major Depression Biomarkers: A systematic review.
    Serati M; Redaelli M; Buoli M; Altamura AC
    J Affect Disord; 2016 Mar; 193():391-404. PubMed ID: 26802316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-γ Agonists for the Treatment of Major Depression: A Review.
    Colle R; de Larminat D; Rotenberg S; Hozer F; Hardy P; Verstuyft C; Fève B; Corruble E
    Pharmacopsychiatry; 2017 Mar; 50(2):49-55. PubMed ID: 27978584
    [No Abstract]   [Full Text] [Related]  

  • 20. Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders.
    de Melo LGP; Nunes SOV; Anderson G; Vargas HO; Barbosa DS; Galecki P; Carvalho AF; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():34-50. PubMed ID: 28438472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.